Stability of whole blood over time for CD4 & Viral load determination in HIV infected persons. N. Sippy & A. Abayomi Ladymeade Reference Unit Laboratory.

Slides:

Advertisements

Similar presentations

Allison Dunning, M.S. Research Biostatistician

Advertisements

ARV Nurse Training, Africaid, 2004 ARV Nurse Training Programme Marcus McGilvray & Nicola Willis Antiretrovirals in Children.

Pediatric Diagnosis of HIV-1 Infection Using Dried Blood Spots Chin-Yih Ou, PhD NCHSTP/DHAP Centers for Disease Control and Prevention.

Estimating the number of Kentuckians living with HIV disease with unmet needs for HIV-related primary care in calendar year 2010  Reducing new HIV infections.

Use of Dried Blood Spots (DBS) Specimens for Measuring HIV-1 Viral Load in Argentina M. Lorena Vázquez Inés Zapiola Ana Gun Silvia Gómez Alejandro Krolewiecki.

Declining HIV Prevalence among young women in Botswana: Results from the 2009 ANC Sentinel Surveillance survey Authors: Yadav Bindeshwar P Anderson Marina.

Evaluation of Point-Of-Care CD4 and Toxicity Monitoring for Resource-Limited ART Clinic Settings in Mozambique Ilesh V. Jani 1, Nádia Sitoe 1, Patrina.

GTP Scenario # 2 September 17,2005. Scenario # 2 Dr. Good received IND approval for CD8 depletion of allogeneic PBMC for a Phase I/II clinical trial.

Marian Kerbleski, RN UCSF AIDS Division San Francisco General Hospital.

Dr Samah Kotb Lecturer of Biochemistry 1 CLS 432 Dr. Samah Kotb Nasr El-deen Biochemistry Clinical practice CLS 432 Dr. Samah Kotb Nasr.

31 subjects with sufficient viable cells studied for T cell and MAIT cell phenotype * One subject was excluded from CD38+HLA-DR+ T cell analysis 30 subjects.

Unit 5: Core Elements of HIV/AIDS Surveillance

1 Lecture 3: Laboratory Diagnostics in ARV Therapy delivered by Dr. Madisa Mine, Botswana Ministry of Health KITSO AIDS Training Program.

Possible solution: Change testing & care for patients in TB treatment Old system TB patient treated at TB center Referred to VCT center for HIV testing.

BOHB APCCB LABORATORY USE OF THE ABBOTT MEDISENSE METER FOR BETA-HYDROXYBUTYRATE MEASUREMENT. GRD Jones, A Screnci, P Graham Chemical Pathology,

2 About HIV: Teaching Tool. About HIV: A teaching tool © 2nd edition 2006 This tool was developed by the François-Xavier Bagnoud Center at the University.

DNA methylation as an epigenetic marker in HIV-2 disease in West Africa? Alberta Davis MRC Laboratories, Gambia 18th January 2013.

The Journey of Blood. Blood - the life source Slide 1: Blood is a scarce and vital resource which saves lives and improves the health of millions. Its.

Persisting long term benefit of genotypic guided treatment in HIV infected patients failing HAART and Importance of Protease Inhibitor plasma levels. Viradapt.

A cost-effectiveness evaluation of preventive interventions for HIV-TB in Sub-Saharan Africa (Tanzania): Relevance for neurological infections Lucie Jean-Gilles.

Track A: Basic Science This track highlighted all aspects of HIV structure, replication, and the host immune responses and led to a greater understanding.

ABSTRACT Background: A retrospective medical record review was conducted to evaluate implementation of the Public Health Service recommendations for laboratory.

The Role of the CPCDMS in QM Activities Elizabeth Love, MPH Harris County Public Health and Environmental Services Department HIV Services Section.

Involving the Community in HIV/AIDS Treatment Support Programmes: An Evidence-Based Approach.

DEVELOPMENT OF THE TOOLS FOR PCR-DETECTION OF HEPATITIS A AND C VIRUSES IN INTRAHOSPITAL VIRAL CONTAMINATION RESEARCH. 1 D. I. Ivanovsky Virology Institute,

Improving Data Entry of CD4 Counts March Welcome! The State Office of AIDS (OA) is continuing to work with providers to improve the quality of data.

QUALITY ASSURANCE Reference Intervals Lecture 4. Normal range or Reference interval The term ‘normal range’ is commonly used when referring to the range.

Laboratory Assessment Tool-LAT Philippe Dubois April 2-12, 2013 Phom Penh, Cambodia.

HIV Care Continuum, District 8- 2 Southwest (Albany), Georgia, 2012.

Older and wiser: continued improvements in clinical outcome and highly active antiretroviral therapy (HAART) response in HIV-infected children in the UK.

1 Counseling and HIV Testing HAIVN Harvard Medical School AIDS Initiatives in Vietnam.

HIV Cellular Pathogenesis III Benhur Lee, M.D.. Adult v. infant (IgG v. IgA) CTL response (MHC tetramers) p24 antigenimia Ab response Viral load.

HIV Care Continuum Persons Living With HIV, Georgia, 2012.

PhD We knew nothing about the set-point viral loads. What was unknown about HIV-1 infection before this paper was published in 2007? 1.Virus density.

Biochemistry Clinical practice CLS 432 Dr. Samah Kotb Lecturer of Biochemistry 2015 Introduction to Quality Control.

Transfusion Medicine Transport of Blood, Blood Components and Derivatives within a Facility DSM Educational Resource Materials for the Training of Facility.

Evolution of the Functional Profile of HIV-Specific CD8+ T cells in a Cohort of Long Term Nonprogressors M López, N Rallón, A Peris, M Salgado, B Rodés,

Page 1 Social and socio-economic benefits of antiretroviral therapy adherence among HIV-infected people who use illicit drugs in Vancouver, Canada Lindsey.

Conclusions Materials and Methods Background Objectives HIV-1 RNA is the most significant determinant of cervical HIV-1 shedding. Shedding has also been.

A Survival Comparison between HIV+ U.S.-born Latinos and Foreign-born Latinos in Houston, Texas Raouf Arafat, MD, MPH, Adebowale Awosika- Olumo.

11 Laboratory Quality Improvement for clinical HIV/AIDS Services in the Uniformed Forces Mwaibako, J, Shija, L; Haverkamp, G; van den Hombergh; Katebalila,

HAART Initiation Within 2 Weeks of Seroconversion Associated With Virologic and Immunologic Benefits Slideset on: Hecht FM, Wang L, Collier A, et al. A.

CD4 trajectory among HIV positive patients receiving HAART in a large East African HIV care centre Agnes N. Kiragga 1, Beverly Musick 2 Ronald Bosch, Ann.

Clinic systems should be adapted to maximize the benefits of point-of-care CD4 technology Point-of-Care CD4 Systems Integration in Uganda December 2011.

 Efficacy of Nevirapine Administration on the Mother to Child Transmission of HIV using a modified HIVNET 012 regimen. M. A St John*, Alok Kumar*, Kelly.

Expression Analysis of α4 integrin and related genetic polymorphisms in HIV acquisition and disease progression OF infected individuals Livia R. GóeS 1,

Learning objectives Review HIV treatment goals

Learning objectives Define HIV treatment goals

EVALUATING STABILIZATION TUBES FOR STORAGE OF CD4 HIV POSITIVE SAMPLES AT KILIFI DISTRICT HOSPITAL, KENYA Nella Raphael Kalama.

Prof. Emmanuel Ohene Afoakwa Department of Nutrition and Food Science

A Question of Stability. Stability of GC and CT nucleic acids in Urine

Unit 4: Monitoring Data Quality For HIV Case Surveillance Systems

Pediatrics HIV/AIDS and PMTCT research in Barbados: lessons learned for monitoring the epidemic and evaluating the interventions. ALOK KUMAR, MD. Lecturer.

Evaluation of Alere q HIV-1/2 VL Plasma

Discussion and Conclusions

HIV Care Continuum in Manhattan

Jeopardy Game Hosted by PHDP Jamaica MODULE 4 Treatment Literacy.

Utilizing research as an opportunity to strengthen

VL patient support: General education at different levels

Immunologic and virological response to ART among HIV infected individuals at a tertiary hospital in Ghana ¹Obiri-Yeboah Dorcas, School of Medical Sciences,

Quality Assurance Reference Intervals.

Polymerase Chain Reaction (PCR)

VL Monitoring updates Dr Miriam Murungi.

Towards the last 90% of the 90:90:90 strategy: A review of viral suppression rates in a HIV program in Central and Eastern Kenya Dr Moses Kitheka,

monitoring & evaluation THD Unit, Stop TB department WHO Geneva

Biomarkers as Endpoints

Rapid Detection of HIV-1 subtype C Integrase resistance mutations by the Use of High-Resolution Melting Analysis Tendai Washaya BSc, Msc. Pre-PhD Student.

Introduction and current status of viral load access

Undetectable = Untransmittable

Public Health Implications

Presentation transcript:

Stability of whole blood over time for CD4 & Viral load determination in HIV infected persons. N. Sippy & A. Abayomi Ladymeade Reference Unit Laboratory Ministry of Health

CD4 & Viral load CD4 is a marker on lymphocytes that serves as the host for HIV entry and replication. The CD4+ cell count is a reflection of circulating CD4+ lymphocytes. As the disease progresses the CD4 cell count decreases. Viral load (VL) is the amount of virus copies that are present in blood.

These 2 laboratory parameters are essential to initiate antiretroviral therapy and monitor treatment response. Determined from whole blood. Ideally, samples should be analysed within 24 hours for CD4+ counts. Viral load samples if not analysed immediately can be stored at -70 C and prepared in batches for analysis.

Why conduct stability studies? Unprocessed samples for CD4 & VL testing deteriorate over prolonged storage times & varying temperatures. Therefore it is important for quality control that the time limits and optimum temperatures for storage are determined if samples are to be transported from remote facilities to processing laboratories.

Aim To determine the optimum temperature and time limits for storage of whole blood for CD4& VL testing in samples.

Methodology Viral load 10 samples stored for up to 72 hours (3 days) as: whole blood at fridge temperature (4  C) and whole blood and room temperature (22  C controlled air-conditioned environment). Samples were tested at 0 hours, 48 hours and 72 hours.

Methodology CD4+ Lymphocyte counts: 8 samples stored at room temperature (22  C controlled air-conditioned environment). Each sample was also mixed on Day 0 with a preservative solution & stored at fridge temperature (4  C). Samples were tested at 24 hour intervals for up to 96 hours. Comparison was made between CD4+ counts determined from non-preserved and preserved blood.

Study Design (VL) Day 1 Day 2 Day 3 WB - 4 C Day 0 Sample WB - 22 C WB- Whole blood

Study Design (CD4) Day 1 Day 2 Day 3 Day 4 P.WB - 4 C Day 0 Sample NP.WB - 22 C P.WB- preserved whole blood; NP. WB-non-preserved whole blood

Results Not more than 0.5 log (three-fold) variation in VL from the 0 hour value  

Results No significant difference in CD4+ counts in preserved and non-preserved samples up to 96 hours from Day 0. Less variability in CD4+ counts in preserved blood over time. Red line: P.WB; Green line: NP. WB

Conclusions LRU can receive samples from peripheral clinics in Barbados for VL and CD4 + count determinations once samples are held at room temperature (~ 22  C) for up to 24 hours. Regional nations can send whole blood at fridge temperature for VL & whole blood mixed with preservative reagent at fridge temperature for CD4+ counts up to 4 days after collection.

Study benefits Tremendous implications for regional management of HIV/AIDS in terms of access to accurate and reliable CD4 & VL results. Provides incentive for further work: Evaluating longer time limits for storage Evaluating dry blood/plasma spots for VL analysis

Enjoy the rest of your Day! We thank all members of Staff at the LRU laboratory and Clinic and staff at the QEH laboratory. Sincere Thanks to Miss Heddy Broome (CDRC) for statistical analysis. Enjoy the rest of your Day!